Potential benefit of osismertinib plus bevacizumab in leptomeningeal metastasis with EGFR mutant non-small-cell lung cancer

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1479-5876
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
Potential benefit of osismertinib plus bevacizumab in leptomeningeal metastasis with EGFR mutant non-small-cell lung cancer ; volume:20 ; number:1 ; day:14 ; month:3 ; year:2022 ; pages:1-12 ; date:12.2022
Journal of translational medicine ; 20, Heft 1 (14.3.2022), 1-12, 12.2022

Creator
Yi, Yali
Cai, Jing
Xu, Peng
Xiong, Le
Lu, Zhiqin
Zeng, Zhimin
Liu, Anwen
Contributor
SpringerLink (Online service)

DOI
10.1186/s12967-022-03331-9
URN
urn:nbn:de:101:1-2022060701182738851321
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
15.08.2025, 7:31 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Associated

  • Yi, Yali
  • Cai, Jing
  • Xu, Peng
  • Xiong, Le
  • Lu, Zhiqin
  • Zeng, Zhimin
  • Liu, Anwen
  • SpringerLink (Online service)

Other Objects (12)